{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:41:32Z","timestamp":1777318892821,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.crad.2023.04.005","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T19:51:21Z","timestamp":1682797881000},"page":"e574-e581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Endometrioid adenocarcinoma: combined multiparametric MRI and tumour marker HE4 to evaluate tumour grade and lymphovascular space invasion"],"prefix":"10.1016","volume":"78","author":[{"given":"X.N.","family":"Yue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.Y.","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.crad.2023.04.005_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"3\u20135","key":"10.1016\/j.crad.2023.04.005_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2007.09.020","article-title":"Novel molecular profiles of endometrial cancer-new light through old windows","volume":"108","author":"Doll","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl. 2","key":"10.1016\/j.crad.2023.04.005_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijgo.12612","article-title":"Cancer of the corpus uteri","volume":"143","author":"Amant","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.crad.2023.04.005_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.crad.2023.04.005_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12957-019-1620-x","article-title":"Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma","volume":"17","author":"Veade","year":"2019","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.crad.2023.04.005_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygyno.2019.09.016","article-title":"LVSI positive and NX in early endometrial cancer: surgical restaging (and no further treatment if N0), or adjuvant ERT?","volume":"156","author":"Harris","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.crad.2023.04.005_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ijgo.12608","article-title":"FIGO cancer report 2018","author":"Bhatla","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.crad.2023.04.005_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2020.12.029","article-title":"Endometrial cancer: a systematic review of HE4, REM and REM-B","volume":"515","author":"Degez","year":"2021","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.crad.2023.04.005_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40644-015-0037-1","article-title":"Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies","volume":"15","author":"Hameeduddin","year":"2015","journal-title":"Cancer Imaging"},{"issue":"3","key":"10.1016\/j.crad.2023.04.005_bib10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.eururo.2013.05.045","article-title":"Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T","volume":"64","author":"Vos","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2023.04.005_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ijgo.13866","article-title":"Cancer of the corpus uteri: 2021 update","author":"Koskas","year":"2021","journal-title":"Int J Gynaecol Obstetr"},{"issue":"2","key":"10.1016\/j.crad.2023.04.005_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Koh","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.crad.2023.04.005_bib13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00261-019-02096-y","article-title":"Staging MRI of uterine malignant mixed M\u00fcllerian tumors versus endometrial carcinomas with emphasis on dynamic enhancement characteristics","volume":"45","author":"Garza","year":"2020","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"10.1016\/j.crad.2023.04.005_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/CCO.0000000000000385","article-title":"Novel imaging techniques in gynaecological cancer","volume":"29","author":"Vandecaveye","year":"2017","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"10.1016\/j.crad.2023.04.005_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1148\/radiol.15141212","article-title":"Endometrial cancer: combined MR volumetry and diffusion-weighted imaging for assessment of myometrial and lymphovascular invasion and tumor grade","volume":"276","author":"Nougaret","year":"2015","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.crad.2023.04.005_bib16","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/jmri.27241","article-title":"Evaluating the relationship between dynamic contrast-enhanced MRI (DCE-MRI) parameters and pathological characteristics in breast cancer","volume":"52","author":"Kang","year":"2020","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"10.1016\/j.crad.2023.04.005_bib17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/jmri.26301","article-title":"Radiomics analysis of multiparametric MRI evaluates the pathological features of cervical squamous cell carcinoma","volume":"49","author":"Wu","year":"2019","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.crad.2023.04.005_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12672-022-00464-7","article-title":"DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer","volume":"13","author":"Qu","year":"2022","journal-title":"Discov Oncol"},{"issue":"1","key":"10.1016\/j.crad.2023.04.005_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02450-5","article-title":"Assessing the reproducibility of high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging in patients with gliomas","volume":"11","author":"Lim","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.crad.2023.04.005_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mri.2021.08.009","article-title":"Quantitative diffusion-weighted imaging and dynamic contrast-enhanced MR imaging for assessment of tumor aggressiveness in prostate cancer at 3T","volume":"83","author":"Fukunaga","year":"2021","journal-title":"Magn Reson Imaging"},{"issue":"1125","key":"10.1016\/j.crad.2023.04.005_bib21","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210054","article-title":"Quantitative diffusion and perfusion MRI in the evaluation of endometrial cancer: validation with histopathological parameters","volume":"94","author":"Satta","year":"2021","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1016\/j.crad.2023.04.005_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.mri.2014.01.009","article-title":"Semiquantitative perfusion combined with diffusion-weighted MR imaging in pre-operative evaluation of endometrial carcinoma: results in a group of 57 patients","volume":"32","author":"Ippolito","year":"2014","journal-title":"Magn Reson Imaging"},{"issue":"6","key":"10.1016\/j.crad.2023.04.005_bib23","first-page":"531","article-title":"Endometrial cancer: diagnostic value of quantitative measurements of microvascular changes with DCE-MR imaging","volume":"27","author":"Ippolito","year":"2014","journal-title":"Magma (New York, NY)"},{"issue":"6","key":"10.1016\/j.crad.2023.04.005_bib24","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/jmri.24730","article-title":"Accuracy of semiquantitative dynamic contrast-enhanced MRI for differentiating type II from type I endometrial carcinoma","volume":"41","author":"Fukunaga","year":"2015","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.crad.2023.04.005_bib25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2004.08.042","article-title":"Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma","volume":"95","author":"Emoto","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.crad.2023.04.005_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.semcancer.2010.06.004","article-title":"Tumour-microenvironmental interactions: paths to progression and targets for treatment","volume":"20","author":"Box","year":"2010","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"10.1016\/j.crad.2023.04.005_bib27","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2174\/1389201020666190718164431","article-title":"Expression Profile of VEGF-C, VEGF-D, and VEGFR-3 in different grades of endometrial cancer","volume":"20","author":"Oplawski","year":"2019","journal-title":"Curr Pharm Biotechnol"},{"issue":"13","key":"10.1016\/j.crad.2023.04.005_bib28","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2014a pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.crad.2023.04.005_bib29","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.3802\/jgo.2021.32.e11","article-title":"Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer","volume":"32","author":"Tortorella","year":"2021","journal-title":"J Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.crad.2023.04.005_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.diii.2020.01.003","article-title":"Prediction of tumor grade and lymphovascular space invasion in endometrial adenocarcinoma with MR imaging-based radiomic analysis","volume":"101","author":"Bereby-Kahane","year":"2020","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.crad.2023.04.005_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejrad.2018.04.008","article-title":"Prediction of histological grade of endometrial cancer by means of MRI","volume":"103","author":"Bonatti","year":"2018","journal-title":"Eur J Radiol"},{"issue":"12","key":"10.1016\/j.crad.2023.04.005_bib32","first-page":"1399","article-title":"Diffusion-weighted MRI at 3T in endometrial cancer: correlation of apparent diffusion coefficient with histopathological prognostic parameters","volume":"31","author":"Ozturk","year":"2021","journal-title":"J Coll Phys Surg Pakistan"},{"issue":"11","key":"10.1016\/j.crad.2023.04.005_bib33","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/aogs.12235","article-title":"HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)","volume":"92","author":"Antonsen","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.crad.2023.04.005_bib34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00404-019-05276-9","article-title":"Risk factors for pelvic lymph node metastasis in endometrial cancer","volume":"300","author":"Li","year":"2019","journal-title":"Arch Gynecol Obstetr"},{"issue":"6","key":"10.1016\/j.crad.2023.04.005_bib35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5306\/wjco.v11.i6.378","article-title":"Preoperative markers for the prediction of high-risk features in endometrial cancer","volume":"11","author":"Panyavaranant","year":"2020","journal-title":"World J Clin Oncol"},{"issue":"4","key":"10.1016\/j.crad.2023.04.005_bib36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/cam4.4486","article-title":"Preoperative magnetic resonance imaging predicts clinicopathological parameters and stages of endometrial carcinomas","volume":"11","author":"Wu","year":"2022","journal-title":"Cancer Med"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926023001691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926023001691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:13:16Z","timestamp":1762114396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926023001691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0009926023001691"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2023.04.005","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometrioid adenocarcinoma: combined multiparametric MRI and tumour marker HE4 to evaluate tumour grade and lymphovascular space invasion","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2023.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}